Stereotactic Body Radiation Therapy for Un-biopsied Early- Stage Non Small Cell Lung Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Non Small Cell Lung Cancer
Interventions
RADIATION

Group 1: Peripherally Located Tumors

Group 1: For peripherally located tumors patients will receive SBRT(Stereotactic Body Radiation Therapy) , 3 fractions of 18 Gy to a total dose of 54 Gy, with a minimum of 40 hours between each treatment fraction is required. ( Gy = Gray and is the unit used to measure the total amount of radiation a patient is exposed to)

RADIATION

Group 2: Peripherally Located Chest Wall Adjacent Tumors

Group 2: For chest wall adjacent tumors patients will receive SBRT (Stereotactic Body Radiation Therapy) , 5 fractions of 12 Gy to a total dose of 60 Gy, with a minimum of 40 hours between each treatment fraction is required. ( Gy = Gray and is the unit used to measure the total amount of radiation a patient is exposed to)

RADIATION

Group 3: Centrally Located Tumors

Group 3: For central tumors patients will receive SBRT (Stereotactic Body Radiation Therapy) , 5 fractions of 10 Gy to a total dose of 50 Gy, with a minimum of 40 hours between each treatment fraction is required. ( Gy = Gray and is the unit used to measure the total amount of radiation a patient is exposed to)

Trial Locations (2)

60141

Edward Hines Jr, VA Hospital, Hines

60153

Loyola University Medical Center, Maywood

All Listed Sponsors
lead

Loyola University

OTHER

NCT02950337 - Stereotactic Body Radiation Therapy for Un-biopsied Early- Stage Non Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter